BIOCYTICS AND EREMID GENOMIC SERVICES COLLABORATE ON RESEARCH STUDY FOR NOVEL SINGLE-CELL TRANSCRIPTOMICS IMMUNE-BASED CANCER CELL THERAPY

HUNTERSVILLE, N.C., Sept. 18, 2026 /PRNewswire/ -- BioCytics, Inc., has engaged Eremid® Genomic Services to help sequence an autologous immune cell fraction that is the leading candidate of BioCytics' immune-based cancer cell therapy efforts. Eremid will perform single cell transcriptomic...